(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-isopropyl-5-methylphenoxy)tetrahydro-2H-pyran-3,4,5-triol

Catalog No. :
ACZGKX059
CAS No. :
20772-23-0
Molecular Formula :
C16H24O6
Molecular Weight :
312.36

IUPAC Name:(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(2-isopropyl-5-methylphenoxy)tetrahydro-2H-pyran-3,4,5-triol

(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-isopropyl-5-methylphenoxy)tetrahydro-2H-pyran-3,4,5-triol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$866.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-isopropyl-5-methylphenoxy)tetrahydro-2H-pyran-3,4,5-triol
IUPAC Name(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(2-isopropyl-5-methylphenoxy)tetrahydro-2H-pyran-3,4,5-triol
MDL No.MFCD00080959
Molecular FormulaC16H24O6
Molecular Weight312.36
SMILESCC1=CC(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O)=C(C(C)C)C=C1
InChI KeyGKQGIQVSMCHAFX-IBEHDNSVSA-N
SynonymTHYMOL-B-D-GLUCOPYRANOSIDE;THYMOL-BETA-D-GLUCOPYRANOSIDE;(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-(5-methyl-2-propan-2-yl-phenoxy)oxane-3,4,5-triol;1-o-Thymyl-beta-D-glucopyranoside;beta-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl;Glucopyranoside, 1-o-thymyl-, beta-D-;Thymol-beta-D-glucoside;β-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl
CAS No.20772-23-0

Synthetic Route by SureRoute

1. ACZGKX059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZGKX059 route product structure diagram
    ACZGKX05920772-23-0
Inquiry

2. ACZGKX059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZGKX059 route product structure diagram
    ACZGKX05920772-23-0
Inquiry

Comments (0)